Nephros Stock Market Value
| NEPH Stock | USD 2.03 0.04 2.01% |
| Symbol | Nephros |
Nephros Price To Book Ratio
Is Nephros' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nephros. If investors know Nephros will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nephros listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.15) | Revenue Per Share 1.371 | Quarterly Revenue Growth 0.272 | Return On Assets (0.09) | Return On Equity (0.18) |
The market value of Nephros is measured differently than its book value, which is the value of Nephros that is recorded on the company's balance sheet. Investors also form their own opinion of Nephros' value that differs from its market value or its book value, called intrinsic value, which is Nephros' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nephros' market value can be influenced by many factors that don't directly affect Nephros' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nephros' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nephros is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nephros' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nephros 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nephros' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nephros.
| 03/20/2024 |
| 04/19/2024 |
If you would invest 0.00 in Nephros on March 20, 2024 and sell it all today you would earn a total of 0.00 from holding Nephros or generate 0.0% return on investment in Nephros over 30 days. Nephros is related to or competes with Precision Optics, Repro Med, InfuSystems Holdings, Utah Medical, Milestone Scientific, Pro Dex, and Coloplast. Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United St... More
Nephros Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nephros' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nephros upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.24) | |||
| Maximum Drawdown | 17.07 | |||
| Value At Risk | (7.46) | |||
| Potential Upside | 2.99 |
Nephros Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nephros' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nephros' standard deviation. In reality, there are many statistical measures that can use Nephros historical prices to predict the future Nephros' volatility.| Risk Adjusted Performance | (0.13) | |||
| Jensen Alpha | (0.80) | |||
| Total Risk Alpha | (1.06) | |||
| Treynor Ratio | (0.75) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nephros' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Nephros Backtested Returns
Nephros has Sharpe Ratio of -0.24, which conveys that the firm had a -0.24% return per unit of risk over the last 3 months. Nephros exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Nephros' Risk Adjusted Performance of (0.13), mean deviation of 2.53, and Standard Deviation of 3.36 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.99, which conveys possible diversification benefits within a given portfolio. Nephros returns are very sensitive to returns on the market. As the market goes up or down, Nephros is expected to follow. Nephros has an expected return of -0.83%. Please make sure to verify Nephros skewness, as well as the relationship between the rate of daily change and price action indicator , to decide if Nephros performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.19 |
Very weak predictability
Nephros has very weak predictability. Overlapping area represents the amount of predictability between Nephros time series from 20th of March 2024 to 4th of April 2024 and 4th of April 2024 to 19th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nephros price movement. The serial correlation of 0.19 indicates that over 19.0% of current Nephros price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.19 | |
| Spearman Rank Test | 0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Nephros lagged returns against current returns
Autocorrelation, which is Nephros stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nephros' stock expected returns. We can calculate the autocorrelation of Nephros returns to help us make a trade decision. For example, suppose you find that Nephros has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nephros regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nephros stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nephros stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nephros stock over time.
Current vs Lagged Prices |
| Timeline |
Nephros Lagged Returns
When evaluating Nephros' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nephros stock have on its future price. Nephros autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nephros autocorrelation shows the relationship between Nephros stock current value and its past values and can show if there is a momentum factor associated with investing in Nephros.
Regressed Prices |
| Timeline |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Nephros in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Nephros' short interest history, or implied volatility extrapolated from Nephros options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Nephros Correlation, Nephros Volatility and Nephros Alpha and Beta module to complement your research on Nephros. For more detail on how to invest in Nephros Stock please use our How to Invest in Nephros guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Nephros Stock analysis
When running Nephros' price analysis, check to measure Nephros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nephros is operating at the current time. Most of Nephros' value examination focuses on studying past and present price action to predict the probability of Nephros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nephros' price. Additionally, you may evaluate how the addition of Nephros to your portfolios can decrease your overall portfolio volatility.
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |
Nephros technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.